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At present the main cause of death originates from cardiovascular diseases. Primarily the most frequent cause is vessel clos-
ing thus resulting in tissue damage. The stent can help to avoid this. It expands the narrowed vessel section and allows free blood
flow. The good surface quality of stents is important. It also must have adequate mechanical characteristics or else it can be dam-
aged which can easily lead to the fracture of the implant. Thus, we have to consider the importance of the surface treatment of
these implants.
In our experiments the appropriate design was cut from a 1.041 mm inner diameter and 0.100 mm wall thickness nitinol tube by
using Nd:YAG laser device. Then, the stent was subjected to chemical etching. By doing so, the burr created during the laser cutting
process can be removed and the surface quality refined. In our research, we changed the time of chemical etching and monitored the
effects of this parameter. The differently etched stents were subjected to microscopic analysis, mass measurement and in vivo envi-
ronment tests. The etching times that gave suitable surface and mechanical features were identified.
Key words: stent, Nitinol, chemical etching, metallic surface area
1. Introduction
At present the main cause of death originates from
cardiovascular diseases, which primarily affect the
elderly but can affect the young as well as a result of
genetic features and unhealthy lifestyle. Smoking, lack
of exercise, consumption of unhealthy foods, stress,
high blood pressure, diabetes mellitus, hyperlipidaemia
and last but not least genetic inheritance taint the likeli-
ness of the development of these illnesses. In case of
a significant vascular narrowing stents can be used to
restore the normal blood flow. In most cases stents are
haemocompatible metal meshes laser cut from a tube
and treated accordingly. During catheterisation of pe-
ripheral or coronary arteries a contrast material is in-
jected in the patient’s vessels to help X-ray visibility. In
some cases markers are put in the stent so the physician
can place and position the stent by monitoring the
X-ray images [1]–[3].
Two categories of stents can be distinguished de-
pending on the vessel needing expansion. One is the
balloon expandable stent, which material is generally
316L austenitic stainless steel, Co-Cr alloy or Pt-Cr
alloy [4]. The other group is the so-called self-
expanding stents. Usually these are used in peripheral
vessels. These stents require not only to be biologi-
cally compatible but also to be greatly flexible as
these implants can be subject to external forces that
can result in deformation. Without flexibility the
stents would not gain back their original shapes after
the elapse of the forces that had caused the deforma-
tion. Thus, these types of stents should be made of
some sort of shape memory alloy. Materials such as
nickel-titanium, the so-called nitinol alloy, Nb-alloy
or Ta-alloy can serve this purpose [5].
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Other than the biological compatibility, the smooth-
ness of the stent surface touching the tissue is also im-
portant.
An implant with rough surface quality would ir-
ritate the tissue beign directly touched, thus the or-
ganism would not accept it causing excessive cellular
(proliferative) reaction. In terms of stents it is not
extraordinary that restenosis (re-narrowing of ex-
panded vessel sections) happens. If so, the long-term
success of these interventions is limited, because
blood flow will be again limited by the growing vas-
cular tissue inside of the stent [6]. A common
method is to coat the part of the stent which is
touching the tissue with some kind of “organism
friendly” polymer in order to decrease the occurrence
of complications. In some cases an anti-proliferative
drug (for example, paclitaxel, sirolimus, everolimus)
is put on the stent or in the coating to reduce the
chance of restenosis [7], [8]. Another solution to
refine the surface quality and compatibility is to ap-
ply surface treatment. Traditional surface treatments
for biomaterials include mechanical polishing, elec-
tropolishing, chemical etching, heat treatments,
sandblasting and short pinning [9].
Schweizer et al. showed that a simple layer-by-
layer (LbL) deposition of positively charged chitosan
and negatively charged heparin can be used to effi-
ciently modify the native surface of both NiTi and Ti
without any previous treatments [10].
The effect of chemical etching in HF + HNO3
aqueous solutions on nitinol surface chemistry has
been studied by Shabalovskaya et al. [11]. Chemical
etching of nitinol is known to be efficient for the
elimination of defective surface layers and surface
oxidizing [12], [13].
The corrosion behaviour of nitinol in the body is
also of critical importance because of the known
toxicological effects of nickel. Some surface treat-
ments (e.g., chemical etching, electropolishing) im-
prove the biocompatibility and inhibit the migration
of nickel. The stability in the physiological environ-
ment is dependant primarily on the properties of the
mostly TiO2 oxide layer that is present on the surface
[14].
O’Brian et al. investigated a passivation process
for polished nitinol wires and vascular stent compo-
nents, after being given a typical shape setting heat
treatment. Surface analysis indicated that the passiva-
tion reduces Ni and NiO content in the oxide and in-
creases TiO2 content [15].
The success of chemical etching depends on the
applied etchant, the temperature of etching and the
timing of etching. In our research, we conducted in
vitro and in vivo experiments to identify the time in-
terval. In this study, a cooperative work between en-
gineers and a medical research team was carried out
and the samples were placed in the carotid arteries of
rats and histology analysis was also performed. The
diameter of these vessels is around one-tenth of the
human carotid arteries, thus the developed and pro-
duced stents had to be equally smaller than the vaso-
dilator implanted in a human being. However, the
distal left anterior descending coronary artery in hu-
man has a diameter similar to that of the stents used in
our experiments [16]. The aim of our research was to
reproduce and securely achieve the produced nitinol
alloy stents’ etching phase and mainly to identify the
optimal etching time.
2. Materials and methods
The first step in the stent production is to create
the desired mesh design. In our experiments, a tube
with a 1.041 mm inner diameter and 0.100 mm wall
thickness was used, with chemical consistency of
56.8% wt% Ni, balance wt% Ti, 0.021% O,
0.0012% H, 0.002% C, any single trace element
<0.005%. Then the designed sample was cut by
using Nd:YAG solid-state laser. The laser cutting
mechanism is based on the reaction of neodymium
with an yttrium–aluminium-garnet crystal, resulting
in a coherent monochromic (1064 nm wavelength)
laser beam. This heats and melts the material at the
location of contact. The protecting gas (argon) used
during the laser cutting process blows the melted
material out from the hole creating the cutting sur-
face. A number of parameters determine the cutting
quality and by optimising them adequate cutting can
be attained.
Despite the cutting being performed with optimal
parameters, burr still had been created on the stent and
not all pieces had dropped out. Figure 1 shows the
stent parts with burr after the laser cutting process.
This implant does not comply with the conditions of
implantation in a living organism, thus it needs treat-
ment. This justifies the need of chemical etching fol-
lowing the laser cutting process (Fig. 2).
During the chemical etching process the material
and the applied etchant (which is different for every
material) get in chemical reaction. As a result a new
compound is created from the atoms generated on the
surface of the material together with the components
of the etchant and this results in the shrinking of the
material.
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Fig. 1. Struts of the laser cut stent with burr
Fig. 2. The struts of the stent after 220 s etching
The chemical etching intensity is influenced by the
following parameters: the time of etching, the type of
etchant and its temperature. The applied etching
pickle contains hydrogen chloride (HCl) and nitric
acid (HNO3) with dilution ratio of 1:3. The compound
of acids was attenuated with distilled water (50 cm3
etching pickle added to 150 cm3 distilled water). The
etching process was performed in ultra-sound cleaning
equipment, which helped the removal of burrs and
residues. The rest of the parameters were not changed
during our experiment.
We considered the etching successful if the strut,
created during the laser cutting process, was totally
removed; the assisting cuttings, where the laser cut
starts dropped out completely and the strut did not
get damaged disabling its further usage. The etching
time was changed every 20 seconds between 180 and
300 seconds. 180 seconds were the starting period,
because the removal of the burr created during laser
cutting was not possible in shorter time, while the
struts became largely damaged after 300 seconds. In
these experiments, 21 pieces of stents were treated
that were categorised into 7 groups. We etched stent
groups for the same period of time, thus this way we
could examine the reproduction of the process as well.
During chemical etching the structure and me-
chanical features of stents change. The strut charac-
teristics of a given stent pattern and material deter-
mine its protecting ability against external forces. One
important parameter is the width of the struts.  This
plays an important role not just in the mechanical
properties but also in the behaviour in the in vivo en-
vironment, since this determines the surface size con-
tacting directly with the living organism which is
called MSA – Metallic Surface Area. It is practical to
have it in the smallest size to decrease the harmful
effects to the organism; however, this may be at the
expense of mechanical properties.
Stereo-microscopic images were taken before and
after the chemical etching to measure the width of
struts. Image analyser software was used to measure
the exact strut width. The measurements were taken on
2 different struts of a stent and each strut at 4 points.
We did the same process on all stents before and after
etching.
The stent’s mass was measured prior and after the
chemical etching. Firstly, the implants were cleaned
with ethanol to remove any grease, other impurities and
remaining etchant. Then, the mass of the samples was
measured on an analytical scale (0.0001 g accuracy).
3. Results
The measurement of the struts shows how their
width changes in relation to the time of chemical
etching. The changes of the stent struts are presented
in Figs. 3–10. The width examined is indicated with
arrows in Fig. 3.
Fig. 3. Laser cut stent struts
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Fig. 4. Stent struts etched for 180 seconds
Fig. 5. Stent struts etched for 200 seconds
Fig. 6. Stent struts etched for 220 seconds
Fig. 7. Stent struts etched for 240 seconds
Fig. 8. Stent struts etched for 260 seconds
Fig. 9. Stent struts etched for 280 seconds
Fig. 10. Stent struts etched for 300 seconds
Figure 10 shows that the stent struts had thickened
so heavily that they became fractured. Decreasing the
struts width causes the implant to drop its mass. The
stent’s mass may influence the reactions and effects
evoked in the organism.
By analysing the images taken of the differently
etched stent struts and the diagram illustrating the nu-
meric values as well, the shrinkage of width in relation
to longer etching time can be clearly seen (Fig. 11). It is
obvious that the width of struts had not been exactly the
same prior to the cutting. The highest measured value
was 116.7 µm, the smallest was 95.4 µm and the average
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strut width was 106.7 µm. The laser cutting process
gives explanation for this. Even the slightest inaccuracy
can cause noticeable changes in the cut sample and in the
width of stent struts when cutting small size. In terms
of larger samples this error would only cause slighter
changes correlated to the whole stent. The stent’s
mass was decreased by increasing the time of etching
(Fig. 12).
Fig. 11. Changes of strut width of the analysed stents
Fig. 12. Changes of the mass of stents
Fig. 13. The histology photo taken 28 days
after placing a strut in the rat’s carotis
By analysing the histological preparations of the
rat carotid arteries with the implanted nitinol stents we
could observe a relevant vascular stenosis due to
neointimal hyperplasia inside the stents treated by
chemical etching only. Figure 13 shows a hematoxylin
and eosin stained carotid artery cross section 28 days
after stent implantation. Neointimal proliferation first
occurs next to the stent struts, then becoming concen-
tric and significantly narrowing the vessel. Although
cellular proliferative reaction – due to direct pressure
by the stent to the intimal and medial layer of the ar-
tery – cannot be completely avoided, it may be further
reduced by decreasing the endothelial damage by
further treatment of the stent surface.
4. Discussion
One can see in Fig. 11 that after 180 seconds of
etching the width of the struts decreased less than 10%.
A 300 second long etching resulted in width decreasing
by about 60%, so there is additional ~50% compared to
the 180 second etching time. We can conclude that the
etching process is accelerating in the aspect of strut
width decreasing. During the process we have to take
into account that the thickness of the strut is also de-
creasing. Therefore, the height of sidewalls is decreas-
ing, too. The material–acid contact surface is also de-
creasing. In the case of decreasing contact surface, the
material removal is slowing down. Figure 12 verifies this
theory because the mass decreasing slows down with
time. If we assume that the volume of the acid is unlim-
itedly great compared to the stent volume, we can find
that decreasing the contact surface does not cause accel-
eration of the etching. So, there is another explanation
of the accelerated strut width decreasing. The width
decreasing speed is changing significantly between
220 seconds and 240 seconds. The characteristic change
is also observable in Fig. 12. At this point the width
decreasing speed is accelerated while the summarised
material removal is decelerated. Therefore, we have to
find two different processes, which have opposite influ-
ence on material removing. One of these processes can
be decelerating material removal by the decreasing con-
tact surface. Another process is the change of localized
etching speed on the sidewalls, which accelerates the
material removing from the side of the struts. We can
explain these changes by the change in the chemical
composition around the laser cut [17]. During the laser
cutting the constituents can burn out or their ratio can
vary. This modified composition reacts more intensively
with the picking bath than the base material itself.
Based on the results obtained we can state that the
burrs created during the laser cutting process can be
removed with an HCl-HNO3-water etchant mixture.
This composition is different from the mixture in
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Shabalovskaya’s work but appropriate and not too
circumstantial to use like the hydrogen-fluoride con-
tent etching pickle [9].
According to our optical and electron-microscopic
tests we found that the optimal stent etching period is
between 200–240 seconds. This time interval differs
from the applied etching time in other researchers’
work [9]–[15] because there the stent geometry was
not examined. In the case of other stent sizes this treat-
ment time may be different because of the different
sizes and the different laser cut parameters. This etch-
ing time period overlaps with the range of changes in
the strut width decreasing. The etching during this
time is probable to remove all of the modified mate-
rial caused by laser cutting.
The geometries of the implant and the surface
treatments (e.g., chemical etching, electropolishing)
influence the mechanical and other properties (e.g.,
flexibility, Metallic Surface Area) of the stents [18].
By changing the time of chemical etching we can
reach different properties. The struts must be resistant
to the cyclic stress tiring which depends on the condi-
tion and the age of the patient [19], [20].
The surface treatment methods (e.g., chemical
etching, electropolishing) change the resistance to the
corrosion behavior of implants which is an important
property [21], [22]. To observe this behavior further in
vitro and in vivo studies are needed.
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